Recovery From Anthracycline Cardiomyopathy After Long-term Support With a Continuous Flow Left Ventricular Assist Device

Journal of Heart and Lung Transplantation

Volumn 28, Issue 1, 2009, Pages 101-103

  Freilich, Mark ^a   Stub, Dion ^a   Esmore, Donald ^a   Negri, Justin ^a   Salamonsen, Robert ^a   Bergin, Peter ^a   Leet, Angeline ^a   Richardson, Meroula ^a   Taylor, Andrew ^a   Woodard, John ^b   Kaye, David ^a   Rosenfeldt, Franklin ^a  

^a ALFRED HOSPITAL   (Australia)

^b AKC Consultants Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ARTICLE; CARDIOMYOPATHY; CLINICAL FEATURE; HEART ASSIST DEVICE; HEART FAILURE; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; PRIORITY JOURNAL;

ADOLESCENT; ANTHRACYCLINES; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART-ASSIST DEVICES; HUMANS; LYMPHOMA, B-CELL; PREDNISONE; SHOCK, CARDIOGENIC; VINCRISTINE;

EID: 58149233908     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.10.002     Document Type: Article

References (9)

1. Leprince P., Combes A., Bonnet N., et al. Circulatory support for fulminant myocarditis: consideration for implantation, weaning and explantation. Eur J Cardiothorac Surg 24 (2003) 399-403
2. Dandel M., Weng Y., Siniawski H., et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112 (2005) 1-37
3. Esmore D.S., Kaye D., Salamonen R., et al. Initial clinical experience with the VentrAssist left ventricular assist device: the pilot trial. J Heart Lung Transplant 27 (2008) 479-485
4. Fisher N.G., and Marshall A.J. Anthracycline-induced cardiomyopathy. UK Postgrad Med J 75 (1999) 265-268
5. Van Dalen E.C., Caron H.N., Dickinson H.O., and Kremer L.C. Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database Syst Rev (2005) CD003917
6. Wouters K.A., Kremer L.C., Miller T.L., Herman E.H., and Lipshultz S.E. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol 131 (2005) 561-578
7. Conklin K.A. Coenzyme q10 for prevention of anthracycline induced cardiotoxicity. Integr Cancer Ther 4; (2005) 110-130
8. Sander S., Coleman C.I., Patel A.A., Kluger I., and White C.H. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail 12 (2006) 464-472
9. Deng M.C., Edwards L.B., Hertz M.I., et al. Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant 24 (2005) 1182-1187